Castle Biosciences Cash Flow Statement 2018-2024 | CSTL

Fifteen years of historical annual cash flow statements for Castle Biosciences (CSTL).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
202320222021202020192018
$-57.47$-67.14$-31.29$-10.28$5.28$-6.37
$6.84$9.18$3.41$1.31$2.28$0.89
$51.63$16.32$13.00$9.69$-0.59$0.54
$58.47$25.49$16.41$11.00$1.69$1.43
$-14.93$-6.22$-4.63$1.66$-0.90$-8.41
$-3.96$-1.68$0.33$-0.98$-0.36$-0.58
$5.71$0.58$-0.18$0.17$0.56$0.20
$1.97$-1.19$-5.82$4.97$-0.47$0.08
$-6.63$-0.01$-4.10$9.15$0.04$-7.36
$-5.63$-41.66$-18.98$9.87$7.02$-12.30
$-13.61$-5.44$-3.47$-4.75$-0.94$-0.28
$0$0$0$0$0$0
$0$-26.42$-63.18$0$0$0
$-2.58$-134.69$0$0$0$0
$0$0$0$0$0$0
$-2.58$-134.69$0$0$0$0
$0$0$0$0$0$0
$-16.18$-166.55$-66.66$-4.75$-0.94$-0.28
$-0.14$-0.12$-0.01$-27.36$11.68$5.42
$0$0$0$0$0$0
$-0.14$-0.12$-0.01$-27.36$11.68$5.42
$2.98$3.33$6.55$333$76.56$0.04
$2.98$3.33$6.55$333$76.61$10.42
$0$0$0$0$0$0
$-5.13$-1.69$-1.12$0$0$0
$-2.30$1.52$5.42$306$88.29$15.84
$-24.11$-206.69$-80.22$311$94.37$3.27
$51.22$36.32$21.74$8.31$1.25$0.29
$0$0$0$0$0$0